Share: Facebook Twitter LinkedIn
Activity Provided By:

Relias LLC

Current Trends in Respiratory Diseases: Updates for the Primary Care Physician

Access Activity

Overview / Abstract:

Target Audience
This educational program is directed toward primary care physicians, nurses, nurse practitioners, and physician assistants.

Activity Overview
This online, on-demand virtual symposium brings together renowned experts to discuss current trends in diagnosing and treating important pulmonary diseases. Chronic obstructive pulmonary disease (COPD), asthma, pulmonary arterial hypertension (PAH), and rarer lung disorders—including interstitial lung disease (ILD) and idiopathic pulmonary fibrosis—have significant associated morbidity and mortality. Because of this, research into new therapies for these diseases is expanding, and novel treatments are being introduced to relieve the burden of these conditions among millions of patients.

As the role of primary care clinicians in a variety of disease states continues to evolve and expand, it is vital that they stay up-to-date on education surrounding current trends in the area. This half-day virtual summit with expert faculty is the ideal platform to close knowledge gaps in a variety of respiratory diseases for the primary care clinician. The activity will provide information on risk factors in pulmonary diseases, diagnostic criteria for rare respiratory diseases, and available and emerging treatment options to manage those diseases.

This educational activity is an archive of a live virtual symposium held on October 31, 2020.

Learning Objectives
Upon successful completion of this activity, you should be better prepared to:

Assess risk factors for pulmonary diseases and describe the diagnostic process
Improve ability to correctly diagnose and differentiate rare respiratory diseases earlier during the course of disease to allow prompt intervention
Compare different treatments available for pulmonary disorders
Evaluate clinical trial data regarding emerging treatments for various pulmonary disorders and the potential use of these agents in clinical practice

Expiration

Nov 17, 2021

Discipline(s)

Physician CME

Format

Online

Credits / Hours

4

Accreditation

ACCME

Presenters / Authors / Faculty

Steven D. Nathan, MD, FCCP
Kristin Highland, MD, FCCP
James P. Lamberti, MD

Sponsors / Supporters / Grant Providers

Bellerophon Therapeutics, Gilead Sciences, Regeneron Pharmaceuticals, Roche, United Therapeutics, Gossamer Bio, Reata Pharmaceuticals, Viela Bio, Genentech, Phillips, Janssen, Sanofi/Regeneron, Actelion, Bayer, Roche, Third Pole Therapeutics, Actelion

Keywords / Search Terms

Relias LLC relias, free CME Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map